Two Canadian urban areas received travelers with severe acute respiratory syndrome (SARS) before the World Health Organization issued its alert. By July 2003, Vancouver had identified 5 cases (4 imported); Toronto reported 247 cases (3 imported) and 43 deaths. Baseline preparedness for pandemic threats may account for the absence of sustained transmission and fewer cases of SARS in Vancouver.
In Canada, 2 urban areas received returning travelers infected with severe acute respiratory syndrome–associated coronavirus (SARS-CoV) from the original Hotel M cluster in Hong Kong. These travelers returned to Canada before the World Health Organization (WHO) issued its first global alert on March 12, 2003. One infected traveler from Hotel M returned to the greater Toronto area (GTA, population 4.7 million), Ontario; 2 returned to the Vancouver census metropolitan area (VCMA, population 2.0 million), British Columbia (BC). GTA, Ontario, is located in central Canada ≈4,000 km from VCMA, BC, which is the westernmost province of Canada. Control of SARS in both GTA and VCMA was by a national, publicly funded, but provincially administered healthcare system. Whereas GTA experienced sustained transmission, VCMA did not. Ultimately, GTA reported 247 patients with SARS and 43 related deaths; 3 cases were imported. VCMA identified 5 confirmed cases, 4 of which were imported (
Neutralization antibody titers to SARS-CoV among patients in VCMA are shown in
| Serum sample no. | Patient 0 | Patient 1 | Patient 2 | Patient 3 | Patient 4 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Days after onset | Titer | Days after onset | Titer | Days after onset | Titer | Days after onset | Titer | Days after onset | Titer | |
| 1 | 10 | 1:32 | 16 | 1:128 | 4 | <1:8 | 3 | <1:8 | 11 | <1:8 |
| 2 | 19 | 1:128 | 29 | 1:32 | 14 | 1:32 | 36 | 1:128 | 28 | 1:32 |
| 3 | 45 | 1:32 | 637 | 1:64 | 20 | 1:128 | 224 | 1:128 | 203 | 1:128 |
| 4 | 217 | 1:128 | 466 | 1:64 | 463 | 1:64 | ||||
| 5 | 481 | 1:64 | ||||||||
*By number of days after symptom onset that serum was collected. SARS, severe acute respiratory syndrome; CoV, coronavirus; VCMA, Vancouver census metropolitan area.
Patient 0 and patient 1 were a couple, who stayed on the 14th floor of Hotel M from February 20 to 24, 2003, and again from March 3 to 6. Both became ill on February 26 (
| Patient characteristics | Patient 0 | Patient 1 | Patient 2 | Patient 3 | Patient 4 | ||
|---|---|---|---|---|---|---|---|
| Baseline characteristics | |||||||
| Sex | Male | Female | Female | Male | Female | ||
| Age (y) | 55 | 54 | 64 | 49 | 44 | ||
| Medical condition | No | Diabetes | Hypertension | No | No | ||
| Epidemiologic characteristics | |||||||
| Travel related | Yes | Yes | Yes | Yes | No | ||
| City of likely source of SARS | Hong Kong | Hong Kong | Hong Kong | Hong Kong | VCMA | ||
| Known contact with SARS | No | No | Yes | No | Yes | ||
| Likely date(s) of exposure, 2003 | Feb 21 | Feb 21 | Mar 19 | Mar 28–30 | Mar 29 or Mar 30 | ||
| Likely setting of exposure | Hotel M | Hotel M | Dinner party | Amoy Gardens | Hospital B | ||
| Date of return to Canada, 2003 | Mar 6 | Mar 6 | Mar 20 | Mar 30 | NA | ||
| Clinical profile | |||||||
| Symptoms and onset, 2003 | |||||||
| Malaise | Feb 26 | Feb 26 | Mar 24 | No | Apr 4 | ||
| Myalgia | No | Feb 28 | Mar 24 | Apr 1 | Apr 10 | ||
| Headache | Feb 28 | Feb 28 | Mar 27 | Apr 1 | Apr 4 | ||
| Fever | Feb 28 | Feb. 28 | Mar 29 | Apr 1 | Apr 15 | ||
| Chills | Feb 28 | Feb 28 | Mar 29 | No | No | ||
| Chest discomfort | No | No | Mar 24 | No | No | ||
| Cough | Mar 1 | No | Mar 29 | No | Apr 11 | ||
| Shortness of breath | Mar 1 | No | Mar 29 | Apr 3 | Apr 11 | ||
| Nausea | No | No | Mar 27 | No | No | ||
| Vomiting | No | No | No | No | No | ||
| Diarrhea | Mar 7 | No | Mar 28 | Apr 6 | Apr 11 | ||
| Hospitalized | Yes | No | Yes | Yes | Yes | ||
| Oxygen saturation (%) on room air at admission | 45 | NA | 80 | 97; fell to 62 within 3 h | 86 | ||
| Aerosolized medication or nebulizer before isolation | No | No | No | No | No | ||
| Date of hospital admission | Mar 7 | NA | Mar 28 | Apr 3 | Apr 15 | ||
| No. days after symptom onset that patient was hospitalized | 10 | 4 | 2 | 11 | |||
| Date of final hospital discharge | Jun 12 | NA | Apr 21 | Apr 21 | May 24 | ||
| ICU | Yes | No | Yes | No | Yes | ||
| Date of ICU admission | Mar 8 | NA | Apr 1 | NA | Apr 15 | ||
| Date of ICU discharge | May 13 | NA | Apr 18 | NA | Apr 24 | ||
| Mechanical ventilation | Yes | No | Yes | No | No | ||
| Delay to implementation at hospital of: | |||||||
| Respiratory precautions† | 15 min‡ | NA | Immediate§ | Immediate§ | 7 min¶ | ||
| Negative-pressure isolation | 165 min‡ | NA | Immediate§ | Immediate§ | 11 min¶ | ||
*SARS, severe acute respiratory syndrome; VCMA, Vancouver census metropolitan area; NA, not applicable; ICU, intensive care unit; ER, emergency room; NPIR, negative-pressure isolation room. †Defined as standard precautions (gloves, gown, eyewear) plus N95 mask and mask on patient when transported. Full respiratory precautions also include NPIR. ‡Arrived in triage March 7, 2003 1:55 p.m. By 2:10 p.m., admission sheet advises "full respiratory precautions" be taken. By 2:20 p.m. in single room in ER. Transferred to NPIR in ER at 4:40 p.m. §Arrived at hospital masked and admitted directly into NPIR. ¶Arrived in ER on April 14, 2003, at 9:49 p.m. Identified as suspected SARS patient at 9:56 p.m. Masked and transferred to NPIR in ER at 10 p.m. Admitted to ICU NPIR on April 15.
His wife, patient 1, was recovering from mild illness, and no further follow-up was arranged. The couple had no other household contacts. Review confirmed that symptoms had not developed in any of the 148 hospital workers involved in patient 0's care by 10 days after his arrival at the hospital. The family physician had no detectable neutralizing antibody to SARS-CoV when tested at day 496.
Patient 2 of the VCMA had prolonged contact abroad with 2 family members in Hong Kong, who subsequently died from SARS. Although asymptomatic, she went to her physician in VCMA on March 26 because she was concerned about her exposure. Chest radiograph showed bilateral consolidation, and she was directed, masked, to hospital B, where she was admitted directly to an NPIR. She was transferred to the ICU of hospital C for assisted ventilation (
Patient 3 stayed at Amoy Gardens March 28–30 (
Patient 4 of the VCMA was a nurse who cared for patient 2 at hospital B from March 29 to 30. At the time, patient 2 was receiving oxygen by mask and nebulization therapy. Patient 4 assisted patient 2 in using the toilet, which was flushed with lid raised in her presence. She followed guidelines in place at the time, but these did not include eye protection. Symptoms developed in the nurse on April 4. She went to hospital E on April 15, where she was admitted directly to an NPIR. Her only household contact remained asymptomatic. Neither he, nor a physician who examined her on April 11, had detectable SARS CoV antibody at 200 and 365 days, respectively.
All 5 patients with SARS in VCMA recovered fully. No additional unrecognized spread was evident. None of 442 staff members of hospitals A–E who participated in a voluntary serosurvey had detectable SARS-CoV antibody by microneutralization assay (details available from corresponding author, upon request).
Mathematical models for SARS, incorporating contact network theory, stress the importance of patient 0 in predicting the likelihood of an epidemic (
Approximately 2,000 passengers land in Vancouver on direct flights from Hong Kong and mainland China every day compared with 500 on average to Toronto. As such, Vancouver is a potential gateway to North America for emerging pathogens from Asia. Because of this perceived risk, the BC Centre for Disease Control (BCCDC) had been increasing preparedness for pandemic threats for several years. An electronic distribution system was established to regularly disseminate communicable disease bulletins to healthcare facilities across the province. When a cluster of unexplained atypical pneumonia in China was reported almost simultaneously with reemergence of influenza A H5N1 in Hong Kong, BCCDC used this well-established communication network to issue an alert on February 20, 2003. The alert requested enhanced vigilance for severe influenzalike illness in returning travelers from mainland China or Hong Kong or among their close contacts. Alerts were repeated February 24, February 28, and March 12, 2003. Before patient 0's arrival, the emergency room at hospital A also participated in an infection control audit that emphasized that barrier precautions should be applied with all acute-onset respiratory infections. Patient 0 thus became the index patient in VCMA and was managed cautiously, even before WHO special alerts were issued. He sought treatment at the cusp of his peak infectious period at a tertiary-care hospital that had been repeatedly primed towards precaution. As a returned traveler, he was a first-generation case. He had no family contacts other than his wife, with whom he had traveled. Infection control precautions were implemented almost immediately upon his arrival at the hospital, limiting opportunities for spread.
When SARS arose in Ontario, a comparable agency to BCCDC did not exist. Responsibility for communicable disease control had shifted over the course of several years to local health boards, which created a decentralized system (
Ultimately, standard droplet and contact precautions proved an effective barrier to SARS except in the context of superspreading events such as aerosolizing procedures (
We thank the patients who generously shared their experience with SARS illness. We acknowledge the health professionals who, during a period of great uncertainty, provided selfless care to them.
This study was funded by the Canadian Institute for Health Research and the BC Centre for Disease Control.
Dr Skowronski is an epidemiologist at the BC Centre for Disease Control, responsible for surveillance, program and policy recommendations, and research related to respiratory-borne and vaccine-preventable diseases.